You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

PROPARACAINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Proparacaine Hydrochloride, and when can generic versions of Proparacaine Hydrochloride launch?

Proparacaine Hydrochloride is a drug marketed by Bausch And Lomb, Rising, Sola Barnes Hind, and Somerset Theraps Llc. and is included in five NDAs.

The generic ingredient in PROPARACAINE HYDROCHLORIDE is proparacaine hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the proparacaine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Proparacaine Hydrochloride

A generic version of PROPARACAINE HYDROCHLORIDE was approved as proparacaine hydrochloride by BAUSCH AND LOMB on September 29th, 1995.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PROPARACAINE HYDROCHLORIDE?
  • What are the global sales for PROPARACAINE HYDROCHLORIDE?
  • What is Average Wholesale Price for PROPARACAINE HYDROCHLORIDE?
Drug patent expirations by year for PROPARACAINE HYDROCHLORIDE
Recent Clinical Trials for PROPARACAINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
American Genomics, LLCPhase 3
Prisma Health-UpstatePhase 4
Vishal JhanjiPhase 4

See all PROPARACAINE HYDROCHLORIDE clinical trials

Pharmacology for PROPARACAINE HYDROCHLORIDE
Drug ClassLocal Anesthetic
Physiological EffectLocal Anesthesia

US Patents and Regulatory Information for PROPARACAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb PROPARACAINE HYDROCHLORIDE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 040074-001 Sep 29, 1995 AT RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sola Barnes Hind PROPARACAINE HYDROCHLORIDE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 084151-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising PROPARACAINE HYDROCHLORIDE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 040277-001 Mar 16, 2000 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sola Barnes Hind PROPARACAINE HYDROCHLORIDE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 084144-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Somerset Theraps Llc PROPARACAINE HYDROCHLORIDE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 215816-001 Aug 9, 2024 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.